skip to Main Content

Surgery Remains the Gold Standard in Pancreatic Cancer Treatment

Newsfeed image, light gray text on dark gray background
Treatment of pancreatic adenocarcinoma is largely dependent on oncologic surgery, according to Katherine Poruk, MD. This is because the systemic therapy landscape for this disease is just starting to expand beyond chemotherapy.

Surgical procedures exist and are effective for patients with resectable and borderline resectable pancreatic tumors. The clinical issue is introduced when patients have metastatic disease because surgery becomes more difficult and often chemotherapy or radiation therapy is needed. Modern advances in care have also brought targeted therapies into the landscape, but there remains in gap in efficacy compared with other gastrointestinal cancers. Read more . . . 



Back To Top